Metastatic Cervical Carcinoma with High-Risk Human Papillomavirus (HPV) Positive and P16/ Ki-67 Positive in a 28 Year-Old Female That Did Not Meet the Current Screening Guidelines
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2015, Vol 2, Issue 2
Abstract
A case presentation about an individual treated at Oklahoma State University Medical Center with high-grade metastatic squamous cell carcinoma of the cervix that was high-risk HPV and p16/Ki-67 positive. The clinical presentation, laboratory data, imaging, and subsequent therapy are reported as well as highlights of screening guidelines for cervical pathology.
Authors and Affiliations
Stephenie Matosich
Bisphenol Compounds on Human Reproduction Health
Bisphenol-A (BPA) is widely used in the plastic industry, and it is one of the well-studied endocrine disrupting chemicals (EDCs). Growing evidence raised the concern of BPA having weak estrogenic activity on human healt...
The Identification of Pregnant Women at Risk for Child Abuse: Methodology
Background: The prevention of child abuse should starts as early as possible in the life of children living in families at risk for abuse. We describe a two-stage selection procedure to identify those pregnant women who...
Pelvic Actinomycosis Masquerading as Malignancy
Pelvic actinomycosis is a chronic granulomatous suppurative disease caused by Actinomyces israeli. The opportunistic anaerobic bacterium Actinomycosis israeli is a normal part of the human flora in the oropharynx, gastro...
High-Throughput Next Generation Sequencing: Applications in Reproductive Diagnosis and Research
The genetic information contained within a cell is transferred through the process of transcription of genes within a genome to produce messenger RNAs (mRNAs) and translation of mRNAs to synthesize proteins. The central...
Pregnancy and Childbirth in Patients With Syndrome-MarfanPregnancy and Childbirth in Patients With Syndrome-Marfan
Marfan syndrome (MFS) is an autosomal dominant condition with a reported incidence rate of 1 in 3000 to 5000 individuals. The majority of cases of MFS are caused by a mutation in the fibrillin-1 gene (FBN1). Transforming...